JAKARTA, Indonesia, June 9, 2026 /PRNewswire/ -- AGIBOT, a global leader in embodied AI and robotics, hosted AGIBOT Partner Conference 2026 in Indonesia (APC...
Postal Service and Ralph Lauren dedicate American Icons in unveiling ceremonyNEW YORK, June 9, 2026 /PRNewswire/ -- The U.S. Postal Service today honored the...
DUBAI, UAE, June 9, 2026 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, is making stock CFD trading completely free via...
Ally Medical Emergency Room is opening in Magnolia, TX near FM 1488 in 2027 — 24/7 care, board-certified physicians, no wait times for Montgomery County.
After a deliberate search for the Commonwealth experience, experienced advisors find their answer inCetera's unique Summit communitySAN DIEGO, June 9, 2026 /PRNewswire/ -- Cetera welcomes...
- BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham
- Elraglusib will be assessed in combination with dinutuximab beta plus chemotherapy in patients with relapsed and refractory neuroblastoma
- Complete response in neuroblastoma patient achieved in Phase 1 study of elraglusib in refractory pediatric cancers
AscellaHealth Establishes International Strategic Advisory Council, Enhances Global Life Sciences Support Services Amid Regulatory and Market Complexity